1. Home
  2. LSAK vs BLDE Comparison

LSAK vs BLDE Comparison

Compare LSAK & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSAK
  • BLDE
  • Stock Information
  • Founded
  • LSAK 1997
  • BLDE 2014
  • Country
  • LSAK South Africa
  • BLDE United States
  • Employees
  • LSAK N/A
  • BLDE N/A
  • Industry
  • LSAK Investment Bankers/Brokers/Service
  • BLDE Aerospace
  • Sector
  • LSAK Finance
  • BLDE Consumer Discretionary
  • Exchange
  • LSAK Nasdaq
  • BLDE Nasdaq
  • Market Cap
  • LSAK N/A
  • BLDE 284.6M
  • IPO Year
  • LSAK N/A
  • BLDE N/A
  • Fundamental
  • Price
  • LSAK $4.96
  • BLDE $3.64
  • Analyst Decision
  • LSAK
  • BLDE Strong Buy
  • Analyst Count
  • LSAK 0
  • BLDE 3
  • Target Price
  • LSAK N/A
  • BLDE $9.33
  • AVG Volume (30 Days)
  • LSAK 43.0K
  • BLDE 717.5K
  • Earning Date
  • LSAK 09-10-2024
  • BLDE 08-07-2024
  • Dividend Yield
  • LSAK N/A
  • BLDE N/A
  • EPS Growth
  • LSAK N/A
  • BLDE N/A
  • EPS
  • LSAK N/A
  • BLDE N/A
  • Revenue
  • LSAK $551,325,000.00
  • BLDE $231,423,000.00
  • Revenue This Year
  • LSAK $9.63
  • BLDE $11.83
  • Revenue Next Year
  • LSAK $8.35
  • BLDE $13.62
  • P/E Ratio
  • LSAK N/A
  • BLDE N/A
  • Revenue Growth
  • LSAK 6.72
  • BLDE 40.46
  • 52 Week Low
  • LSAK $3.00
  • BLDE $2.06
  • 52 Week High
  • LSAK $5.33
  • BLDE $4.36
  • Technical
  • Relative Strength Index (RSI)
  • LSAK 60.42
  • BLDE 67.40
  • Support Level
  • LSAK $4.76
  • BLDE $3.33
  • Resistance Level
  • LSAK $4.84
  • BLDE $3.79
  • Average True Range (ATR)
  • LSAK 0.13
  • BLDE 0.16
  • MACD
  • LSAK 0.02
  • BLDE 0.02
  • Stochastic Oscillator
  • LSAK 89.19
  • BLDE 69.70

About BLDE Blade Air Mobility Inc.

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

Share on Social Networks: